Helius Therapeutics is a New Zealand biotechnology company focused on medicinal cannabis research and development. Helius holds licenses to cultivate, research, develop and import medical cannabis products. In fact, we are New Zealand’s largest licenses cannabis company. We operate from a 8,800sqm state-of-the-art facility in Auckland with controlled growing systems, integrated extraction site, advanced cannabinoid research laboratories and manufacturing operations. As the country's regulatory environment changes, Helius is poised to set the standard for effective and accessible medicinal cannabis products in New Zealand and beyond.

The Academy of Medical Cannabis is an Internationally recognised and leading school of education. Our focus is on educating doctors, and ongoing development of specialised learning on the subject of medical cannabis. Hon. Professor Mike Barnes is the author and Director of Education at The Academy of Medical Cannabis. He is a leading medicinal cannabis expert, and highly experienced consultant neurologist. Medicinal cannabis expert and specialist lecturer, Edmund Bonikowski has held acute and community based NHS posts in neurological rehabilitation. Other participating content authors are medical experts with specialism in their chosen topics.